Mettler-Toledo International (MTD) Price Target Increased to $572.00 by Analysts at Morgan Stanley

Share on StockTwits

Mettler-Toledo International (NYSE:MTD) had its price target upped by Morgan Stanley from $529.00 to $572.00 in a report released on Wednesday morning. The brokerage currently has an equal weight rating on the medical instruments supplier’s stock.

A number of other analysts have also issued reports on the stock. JPMorgan Chase & Co. increased their price target on shares of Mettler-Toledo International from $550.00 to $600.00 and gave the stock a neutral rating in a research report on Friday, July 27th. Zacks Investment Research raised shares of Mettler-Toledo International from a sell rating to a hold rating in a research report on Monday, July 30th. Finally, UBS Group started coverage on shares of Mettler-Toledo International in a research report on Tuesday. They issued a neutral rating and a $625.00 price target for the company. Eleven research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company has an average rating of Hold and an average target price of $623.55.

MTD stock traded down $8.03 during mid-day trading on Wednesday, reaching $559.37. 5,802 shares of the stock traded hands, compared to its average volume of 183,348. The company has a current ratio of 1.46, a quick ratio of 1.06 and a debt-to-equity ratio of 1.92. Mettler-Toledo International has a 52-week low of $540.24 and a 52-week high of $697.26. The firm has a market capitalization of $15.35 billion, a PE ratio of 32.08, a P/E/G ratio of 2.34 and a beta of 1.08.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, July 26th. The medical instruments supplier reported $4.65 EPS for the quarter, beating analysts’ consensus estimates of $4.58 by $0.07. The company had revenue of $722.00 million during the quarter, compared to analyst estimates of $715.69 million. Mettler-Toledo International had a net margin of 13.52% and a return on equity of 90.80%. The business’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the firm earned $3.92 earnings per share. On average, equities research analysts anticipate that Mettler-Toledo International will post 20.15 earnings per share for the current year.

In other Mettler-Toledo International news, Director Robert F. Spoerry sold 1,836 shares of Mettler-Toledo International stock in a transaction on Monday, September 10th. The shares were sold at an average price of $600.00, for a total transaction of $1,101,600.00. Following the sale, the director now owns 7,423 shares in the company, valued at $4,453,800. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction on Thursday, September 6th. The stock was sold at an average price of $590.00, for a total transaction of $177,000.00. Following the sale, the chief financial officer now owns 5,599 shares in the company, valued at approximately $3,303,410. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 18,358 shares of company stock worth $10,744,204. Insiders own 4.80% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. WCM Investment Management CA bought a new position in shares of Mettler-Toledo International during the second quarter valued at $527,205,000. Fiera Capital Corp lifted its holdings in shares of Mettler-Toledo International by 4.1% during the second quarter. Fiera Capital Corp now owns 623,601 shares of the medical instruments supplier’s stock valued at $360,834,000 after acquiring an additional 24,760 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in shares of Mettler-Toledo International by 0.5% during the second quarter. Massachusetts Financial Services Co. MA now owns 552,453 shares of the medical instruments supplier’s stock valued at $319,666,000 after acquiring an additional 2,722 shares during the period. Select Equity Group L.P. lifted its holdings in shares of Mettler-Toledo International by 19.5% during the second quarter. Select Equity Group L.P. now owns 200,210 shares of the medical instruments supplier’s stock valued at $115,848,000 after acquiring an additional 32,648 shares during the period. Finally, Putnam Investments LLC lifted its holdings in shares of Mettler-Toledo International by 23.2% during the second quarter. Putnam Investments LLC now owns 186,390 shares of the medical instruments supplier’s stock valued at $107,851,000 after acquiring an additional 35,046 shares during the period. Hedge funds and other institutional investors own 92.93% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries.

Further Reading: Calculate Your Return on Investment (ROI)

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply